Mast cells as effector cells: a co-stimulating question

Trends in Immunology

Volumn 28, Issue 8, 2007, Pages 360-365

  Bachelet, Ido ^a   Levi Schaffer, Francesca ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR1; FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; INTEGRIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

CELL FUNCTION; CELL STIMULATION; EFFECTOR CELL; HUMAN; IMMUNOCOMPETENT CELL; MAST CELL; NONHUMAN; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD137; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; HUMANS; INTEGRINS; MAST CELLS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 34447518913     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.06.007     Document Type: Review

References (41)

1. Malaviya R., et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381 (1996) 77-80
2. Secor V.H., et al. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191 (2000) 813-822
3. Tanzola M.B., et al. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171 (2003) 4385-4391
4. Dunn M.R., et al. A study of the relationship of mast cells to carcinoma in situ of the uterine cervix. Lab. Invest. 6 (1957) 542-546
5. Constantinides P. Mast cells and susceptibility to experimental atherosclerosis. Science 117 (1953) 505-506
6. Lenschow D.J., et al. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14 (1996) 233-258
7. Bryceson Y.T., et al. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166
8. Besmer P., et al. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320 (1986) 415-421
9. Chabot B., et al. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335 (1988) 88-89
10. Zsebo K.M., et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63 (1990) 213-224
11. Tsai M., et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6382-6386
12. Bischoff S.C., et al. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175 (1992) 237-244
13. Hundley T.R., et al. Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104 (2004) 2410-2417
14. Iwaki S., et al. Btk plays a crucial role in the amplification of FcεRI-mediated mast cell activation by kit. J. Biol. Chem. 280 (2005) 40261-40270
15. Tkaczyk C., et al. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and FcεRI aggregation. Blood 104 (2004) 207-214
16. Gilfillan A.M., et al. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 (2006) 218-230
17. Petti F., et al. Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930. Mol. Cancer Ther. 4 (2005) 1186-1197
18. Tashiro M., et al. Increased secretion of TNF-α by costimulation of mast cells via CD28 and FcεRI. J. Immunol. 158 (1997) 2382-2389
19. Marietta E.V., et al. CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi. J. Immunol. 159 (1997) 2840-2848
20. Piliponsky A.M. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101 (2003) 1898-1904
21. Hamawy M.M., et al. Adherence of rat basophilic leukemia (RBL-2H3) cells to fibronectin-coated surfaces enhances secretion. J. Immunol. 149 (1992) 615-621
22. Ra C., et al. Fibronectin receptor integrins are involved in mast cell activation. J. Allergy Clin. Immunol. 94 (1994) 625-628
23. Kruger-Krasagakes S., et al. Adhesion of human mast cells to extracellular matrix provides a co-stimulatory signal for cytokine production. Immunology 98 (1999) 253-257
24. Bianchine P.J. IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J. Immunol. 149 (1992) 3665-3671
25. Oki T., et al. Integrin αIIbβ3 induces the adhesion and activation of mast cells through interaction with fibrinogen. J. Immunol. 176 (2006) 52-60
26. Bhattacharyya S.P., et al. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J. Leukoc. Biol. 63 (1998) 337-341
27. Inamura N., et al. Induction and enhancement of FcεRI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol. 160 (1998) 4026-4033
28. Nishimoto H., et al. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106 (2005) 4241-4248
29. Caruso R.A., et al. Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations. Anticancer Res. 27 (2007) 391-394
30. Bachelet I., et al. Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic process. J. Biol. Chem. 281 (2006) 27190-27196
31. Lemaitre B., et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
32. Medzhitov R., et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
33. Qiao H., et al. FcεR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107 (2006) 610-618
34. Nigo Y.I., et al. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2286-2291
35. Fehrenbach K., et al. Stimulation of mast cells via FcvarεR1 and TLR2: the type of ligand determines the outcome. Mol. Immunol. 44 (2007) 2087-2094
36. Kulka M., et al. TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol. Immunol. 43 (2006) 1579-1586
37. Toda M., et al. Impact of engagement of FcεRI and CC chemokine receptor 1 on mast cell activation and motility. J. Biol. Chem. 279 (2004) 48443-48448
38. Miyazaki D., et al. Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J. Clin. Invest. 115 (2005) 434-442
39. Price K.S., et al. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13. Am. J. Respir. Cell Mol. Biol. 28 (2006) 420-427
40. Florian S., et al. Detection of novel leukocyte differentiation antigens on basophils and mast cells by HLDA8 antibodies. Allergy 61 (2006) 1054-1062
41. Sun J., et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 13 (2007) 719-724